URGN
URGN
NASDAQ · Biotechnology

Urogen Pharma Ltd

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$30.22
+3.63 (+13.65%)
As of May 9, 1:38 AM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +50.1% upside
Low Target $37.53
Average Target $45.36
High Target $61.85
Current Price $30.22
Current
$30.22
Target
$45.36
$37.53 $45.36 avg $61.85
Scenario Analysis
Bear Case
$37.53
24.2%
Low target
Base Case
$45.36
+50.1%
Avg target
Bull Case
$61.85
+104.7%
High target
Risk/Reward
4.3x
Highly favorable
Price in Context
52-Week High
$30.00
0.7% from high
52-Week Low
$3.42
+783.6% from low
Target vs 52W High
$45.36
+51.2% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.49
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%